Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00754494
First received: September 17, 2008
Last updated: February 7, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2013
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)